Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2005-09-13
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 400
- Registration Number
- NCT00162695
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Treatment of Mature B-cell Lymphoma/Leukaemia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2012-03-28
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 848
- Registration Number
- NCT00162656
- Locations
- π¬π§
Sheffield Children's Hospital, Sheffield, United Kingdom
π«π·Institut Gustave Roussy, Villejuif, France
πΊπΈMorgan Stanley Childrens Hospital of New York Presbyterian, New York, New York, United States
The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas
Phase 3
- Conditions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2007-08-10
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 270
- Registration Number
- NCT00162721
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2012-04-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 87
- Registration Number
- NCT00147160
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
π¬π§Bristol Royal Hospital for Children, Bristol, United Kingdom
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-08-08
- Last Posted Date
- 2005-08-24
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 28
- Registration Number
- NCT00127595
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Early Tracheotomy Versus Prolonged Endotracheal Intubation in Intensive Care Unit (ICU) Patients
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-08-08
- Last Posted Date
- 2005-08-25
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 468
- Registration Number
- NCT00127621
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
Phase 2
Suspended
- Conditions
- First Posted Date
- 2005-08-05
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 37
- Registration Number
- NCT00127088
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
Phase 2
- Conditions
- First Posted Date
- 2005-08-05
- Last Posted Date
- 2006-09-08
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 37
- Registration Number
- NCT00127049
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-08-03
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 55
- Registration Number
- NCT00126230
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
Phase 3
- Conditions
- First Posted Date
- 2005-08-03
- Last Posted Date
- 2006-09-08
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 192
- Registration Number
- NCT00126269
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Β© Copyright 2024. All Rights Reserved by MedPath